These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16202653)

  • 1. Optimising the management of anaemia in patients with cancer with practice guidelines using erythropoiesis-stimulating proteins.
    Smyth D; Zumbrink S
    Eur J Oncol Nurs; 2005; 9 Suppl 1():S3-S13. PubMed ID: 16202653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New EORTC guidelines for the treatment of anaemia in patients with cancer: implications for nursing practice.
    Foubert J
    Eur J Oncol Nurs; 2006 Jul; 10(3):177-86. PubMed ID: 16199202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment.
    Repetto L; Moeremans K; Annemans L;
    Cancer Treat Rev; 2006; 32 Suppl 2():S5-9. PubMed ID: 16725267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and benefits of erythropoiesis-stimulating agents in cancer management.
    Beutel G; Ganser A
    Semin Hematol; 2007 Jul; 44(3):157-65. PubMed ID: 17631180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoetin beta therapy in patients with solid tumours.
    Pronzato P; Jassem J; Mayordomo J
    Crit Rev Oncol Hematol; 2006 Apr; 58(1):46-52. PubMed ID: 16169242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents.
    Aapro MS; Link H
    Oncologist; 2008; 13 Suppl 3():33-6. PubMed ID: 18458123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Summary version of the Standards, Options and Recommendations for the use of recombinant erythropoietin (epoietin-alpha and beta, darbepoietin-alpha, EPO) in the management of anaemia in oncology - Update 2003].
    Spaeth D; Casadevall N; Daouphars M; Marchal C; Marec-Berard P; Fabre N; Haugh M;
    Bull Cancer; 2004 Feb; 91(2):179-88. PubMed ID: 15047458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutropenia management with granulocyte colony-stimulating factors: from guidelines to nursing practice protocols.
    Dolan S; Crombez P; Munoz M
    Eur J Oncol Nurs; 2005; 9 Suppl 1():S14-23. PubMed ID: 16207534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.
    Ludwig H; Aapro M; Bokemeyer C; Macdonald K; Soubeyran P; Turner M; Albrecht T; Abraham I
    Eur J Cancer; 2009 Jun; 45(9):1603-15. PubMed ID: 19278851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal anaemia: recent developments, innovative approaches and future directions for improved management.
    Kerr PG
    Nephrology (Carlton); 2006 Dec; 11(6):542-8. PubMed ID: 17199795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B; van de Werf PR; Melissant CF; Brok RG
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia.
    Spaëth D
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):875-85. PubMed ID: 18533797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alfa-epoietin and anaemia in gynaecological cancer.
    Di Cocco B; Salesi N; Fabi A; Nardoni C; Ferretti G; Bossone G; Ciccarese M; Savarese A; Vecchione A; Cognetti F
    Anticancer Res; 2004; 24(2C):1287-92. PubMed ID: 15154662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of epoetin beta in the treatment of anaemia in patients with gynaecological malignancies.
    Cornes P; Boiangiu I
    Anticancer Res; 2007; 27(1B):513-22. PubMed ID: 17348435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Darbepoetin alfa: new indication/new dosage. No proven advantage in chemotherapy-induced anaemia.
    Prescrire Int; 2005 Oct; 14(79):174-6. PubMed ID: 16285072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of recombinant erythropoietin in childhood cancer.
    Shankar AG
    Oncologist; 2008 Feb; 13(2):157-66. PubMed ID: 18305061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current thinking and treatment practices in anaemia--an interactive poll.
    Spivak JL; Cazzola M
    Med Oncol; 2000 Nov; 17 Suppl 1():S32-7. PubMed ID: 11188784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective observational study of anaemia management in cancer patients - results from the German Cancer Anaemia Registry.
    Steinmetz T; Totzke U; Schweigert M; Mittermüller J; Nawka S; Tesch H; Groschek M; Söling U; Hellebrand E; Tsamaloukas A
    Eur J Cancer Care (Engl); 2011 Jul; 20(4):493-502. PubMed ID: 21029222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the impact of cancer-related anaemia on quality of life and the role of rHuEPO.
    Brandberg Y
    Med Oncol; 2000 Nov; 17 Suppl 1():S23-31. PubMed ID: 11188783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.